A transdisciplinary model to inform randomized clinical trial methods for electronic cigarette evaluation

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Lopez, Alexa A ^a   Cobb, Caroline O ^a   Yingst, Jessica M ^b   Veldheer, Susan ^b   Hrabovsky, Shari ^b   Yen, Miao Shan ^a   Foulds, Jonathan ^b   Eissenberg, Thomas ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Analytical methods; Electronic cigarette; Nnal; Rct

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; CONTROLLED STUDY; ELECTRONIC CIGARETTE; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PENNSYLVANIA; PREVENTION AND CONTROL; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL; SMOKING; THEORETICAL MODEL; VIRGINIA; YOUNG ADULT;

ADULT; AGED; ELECTRONIC CIGARETTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PENNSYLVANIA; QUALITATIVE RESEARCH; RESEARCH DESIGN; SMOKING; VIRGINIA; YOUNG ADULT;

EID: 85007441153     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2792-8     Document Type: Article

References (52)

1. Arrazola RA, Neff LJ, Kennedy SM, Holder-Hayes E, Jones CD, Centers for Disease Control & Prevention. Tobacco use among middle and high school students-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63:1021-6.
2. King BA, Patel R, Nguyen KH, Dube SR. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res. 2015; 17:219-27. doi:10.1093/ntr/ntu191.
3. Breland AB, Spindle T, Weaver M, Eissenberg T. Science and electronic cigarettes: current data, future needs. J Addict Med. 2014;8:223-33. doi:10.1097/ADM.0000000000000049.
4. McRobbie H, Phillips A, Goniewicz ML, Smith KM, Knight-West O, Przulj D, Hajek P. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila). 2015;8:873-8. doi:10.1158/1940-6207.CAPR-15-0058.
5. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: Evidence from a systematic review and meta-Analysis. PLoS One. 2015;10:e0122544. doi:10.1371/journal.pone.0122544.
6. Etter JF. Should electronic cigarettes be as freely available as tobacco? Yes. BMJ. 2013;346:f3845. doi:10.1136/bmj.f3845.
7. Hajek P. Electronic cigarettes have a potential for huge public health benefit. BMC Med. 2014;12:225. doi:10.1186/s12916-014-0225-z.
8. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23 Suppl 2:ii36-ii40. doi:10.1136/tobaccocontrol-2013-051470.
9. England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA. Nicotine and the developing human: A neglected element in the electronic cigarette debate. Am J Prev Med. 2015;49:286-93. doi:10.1016/j.amepre.2015.01.015.
10. Rom O, Pecorelli A, Valacchi G, Reznick AZ. Are e-cigarettes a safe and good alternative to cigarette smoking? Ann NY Acad Sci. 2015;1340:65-74. doi:10.1111/nyas.12609.
11. Stanwick R. E-cigarettes: Are we renormalizing public smoking? Reversing five decades of tobacco control and revitalizing nicotine dependency in children and youth in Canada. Paediatr Child Health. 2015;20:101-5.
12. Williams M, To A, Bozhilov K, Talbot P. Strategies to reduce tin and other metals in electronic cigarette aerosol. PLoS One. 2015;10:e0138933. doi:10.1371/journal.pone.0138933.
13. Chapman S. Should electronic cigarettes be as freely available as tobacco cigarettes? No. BMJ. 2013;346:f3840. doi:10.1136/bmj.f3840.
14. Jollye L. E-cigarettes in the UK: A more inclusive debate is needed. Lancet. 2014;384:1576. doi:10.1016/S0140-6736(14)61985-1.
15. McKee M, Chapman S, Daube M, Glantz S. The debate on electronic cigarettes. Lancet. 2014;384:2107. doi:10.1016/S0140-6736(14)62366-7.
16. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet. 2013;382:1629-37. doi:10.1016/S0140-6736(13)61842-5.
17. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS One. 2013;8:e66317. doi:10.1371/journal.pone.0066317.
18. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2014;231:401-7. doi:10.1007/s00213-013-3249-8.
19. Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol. 2008;16:99-112. doi:10.1037/1064-1297.16.2.99.
20. Shihadeh A, Eissenberg T. Electronic cigarette effectiveness and abuse liability: predicting and regulating nicotine flux. Nicotine Tob Res. 2015;17:158-62. doi:10.1093/ntr/ntu175.
21. Spindle TR, Breland AB, Karaoghlanian NV, Shihadeh AL, Eissenberg T. Preliminary results of an examination of electronic cigarette user puff topography: The effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob Res. 2015;17:142-9. doi:10.1093/ntr/ntu186.
22. Breland AB, Soule E, Lopez AA, Ramôa C, El-Hellani A, Eissenberg T. Electronic cigarettes: What are they and what do they do? Ann NY Acad Sci. 2015. doi:10.1111/nyas.12977.
23. Cervellati F, Muresan XM, Sticozzi C, Gambari R, Montagner G, Forman HJ, Valacchi G. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro. 2014;28:999-1005. doi:10.1016/j.tiv.2014.04.012.
24. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: Findings from a longitudinal online panel survey in great britain. Nicotine Tob Res. 2015;17:1187-94. doi:10.1093/ntr/ntv078.
25. Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, Goniewicz ML. Carbonyl compounds in electronic cigarette vapors: Effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16:1319-26. doi:10.1093/ntr/ntu078.
26. Marini S, Buonanno G, Stabile L, Ficco G. Short-Term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol. 2014;278:9-15. doi:10.1016/j.taap.2014.04.004.
27. Talih S, Balhas Z, Eissenberg T, Salman R, Karaoghlanian N, El Hellani A, Shihadeh A. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res. 2015;17:150-7. doi:10.1093/ntr/ntu174.
28. Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T. Electronic nicotine delivery systems: A research agenda. Tob Control. 2011;20:243-8.
29. Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract. 2011;65:1037-42. doi:10.1111/j.1742-1241.2011.02751.x.
30. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: Randomised cross-over trial. Tob Control. 2010;19:98-103.
31. Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav. 2012;37:970-3. doi:10.1016/j.addbeh.2012.03.004.
32. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidem Biomar. 2010;19:1945-53.
33. Lopez AA, Hiler MM, Soule EK, Ramôa CP, Karaoghlanian NV, Lipato T, Eissenberg T. Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: A preliminary report. Nicotine Tob Res. 2015. doi:10.1093/ntr/ntv182.
34. Vansickel AR, Eissenberg T. Electronic cigarettes: Effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15:267-70. doi:10.1093/ntr/ntr316.
35. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 2015;110:1160-8. doi:10.1111/add.12917.
36. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav. 2014;39:491-4. doi:10.1016/j.addbeh.2013.10.028.
37. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, perceived side effects and benefits of electronic cigarette use: A worldwide survey of more than 19, 000 consumers. Int J Environ Res Public Health. 2014;11:4356-73. doi:10.3390/ijerph110404356.
38. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: A prospective 6-month pilot study of smokers not intending to quit. BMC Public Health. 2014;14:1159. doi:10.1186/1471-2458-14-1159.
39. Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, Russo C. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: Evidence for harm reversal. Int J Environ Res Public Health. 2014;11:4965-77. doi:10.3390/ijerph110504965.
40. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, Fisichella A. Effectiveness and tolerability of electronic cigarette in real-life: A 24-month prospective observational study. Intern Emerg Med. 2014;9:537-46. doi:10.1007/s11739-013-0977-z.
41. Food and Drug Administration. Guidance for Clinical Investigators, Sponsors, and IRBs: Adverse Event Reporting to IRBs -Improving Human Subject Protection. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126572.pdf. Accessed 29 December 2015.
42. Baweja R, Curci KM, Yingst J, Veldheer S, Hrabovsky S, Wilson SJ, Foulds J. Views of experienced electronic cigarette users. Addict Res Theory. 2015. doi:10.3109/16066359.2015.1077947.
43. Soule EK, Nasim A, Rosas S. Adverse effects of electronic cigarette use: A concept mapping approach. Nicotine Tob Res. 2015. doi:10.1093/ntr/ntv246.
44. Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res. 2013;15:e59. doi:10.2196/jmir.2324.
45. Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing selfreported ethanol consumption. In J. Allen & R. Z. Litten (Eds.), Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press. 1992. pp. 41-72.
46. Kessler RC, Green JG, Gruber MJ, Sampson NA, Bromet E, Cuitan M, Zaslavsky AM. Screening for serious mental illness in the general population with the K6 screening scale: Results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res. 2010;19 Suppl1:4-22. doi:10.1002/mpr.310.
47. Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, editors. The social psychology of health. Newbury Park, CA: Sage; 1988.
48. Radloff L. The CES-D scale: A self-report depression scale for research in the general population. Appl Psych Meas. 1977;1:385-401.
49. Breland AB, Kleykamp BA, Eissenberg T. Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob Res. 2006;8:727-38. doi:10.1080/14622200600789585.
50. Research Electronic Database Capture (REDCap). http://www.project-redcap.org. Accessed 29 December 2015.
51. Lopez AA, Eissenberg T. Science and the evolving electronic cigarette. Prev Med. 2015;80:101-6. doi:10.1016/j.ypmed.2015.07.006.
52. Foulds J, Veldheer S, Yingst J, Hrabovsky S, Wilson SJ, Nichols TT, Eissenberg T. Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res. 2015;17:186-92. doi:10.1093/ntr/ntu204.